Fig. 3: Kaplan–Meier curves on validation cohorts (D1-D8) using CollaTIL model. | Communications Medicine

Fig. 3: Kaplan–Meier curves on validation cohorts (D1-D8) using CollaTIL model.

From: Computational pathology identifies immune-mediated collagen disruption to predict clinical outcomes in gynecologic malignancies

Fig. 3

Shown are Kaplan–Meier estimates of OS and PFS for high-risk patients as compared to their low-risk counterparts in a cohort of CSCC patients treated with chemotherapy (D1, n = 134). b cohort of CSCC patients treated with radiotherapy (D2, n = 128). c cohort of EC patients treated with chemotherapy (D3, n = 32). d cohort of EC patients not treated with chemotherapy (D4, n = 26). e cohorts of HGSOC, CSCC, and EC patients treated with immunotherapy in the recurrent setting (D5, D6, D7, n = 48). f cohort of HGSOC patients treated with chemotherapy (D8, n = 30). The statistical significance of differences in survival rates between high-risk and low-risk groups was determined using the log-rank test (P). EC endometrial carcinoma, HGSOC high grade serous ovarian carcinoma, CSCC cervical squamous cell carcinoma, OS overall survival, PFS progression-free survival.

Back to article page